Literature DB >> 7931339

Metabolic abnormalities and grade of encephalopathy in acute hepatic failure.

A M Mans1, M R DeJoseph, R A Hawkins.   

Abstract

Acute hepatic failure is associated with many biochemical abnormalities in plasma and brain. Changes that correlate well with the degree of behavioral impairment may be important factors in the development of encephalopathy. We measured the concentrations of intermediary metabolites, ammonia, and amino acids in brain and plasma and the rate of whole-brain glucose utilization in rats with an acutely devascularized liver. In all rats an estimate of the grade of encephalopathy (reflected by behavioral impairment) was made. Rats underwent portacaval shunting and hepatic artery ligation (or sham operation) and were kept normoglycemic and normothermic thereafter. We sampled blood and whole brain (by near-instantaneous freeze-blowing) 2, 4, or 6 h later. There were no alterations in levels of high-energy phosphate metabolites in the brain or in metabolites associated with the glycolytic pathway and Krebs cycle, except lactate and pyruvate. Brain glucose use was decreased similarly at all times after surgery. Levels of ammonia and many amino acids were increased in brain and plasma; brain aspartate, glutamate, and arginine levels were decreased. The increases in content of plasma ammonia and brain glutamine, proline, alanine, and aromatic amino acids and the decreases in brain aspartate and glutamate were most strongly correlated with behavioral impairment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931339     DOI: 10.1046/j.1471-4159.1994.63051829.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Mild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospects.

Authors:  Nicolas Chatauret; Christopher Rose; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Cerebral ammonia uptake and accumulation during prolonged exercise in humans.

Authors:  Lars Nybo; Mads K Dalsgaard; Adam Steensberg; Kirsten Møller; Niels H Secher
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 3.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 4.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

5.  Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons.

Authors:  Touraj Shokati; Claudia Zwingmann; Dieter Leibfritz
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 6.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

Review 7.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

Review 8.  Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.

Authors:  Arthur J L Cooper
Journal:  Metab Brain Dis       Date:  2012-10-13       Impact factor: 3.584

9.  Microglia contribute to ammonia-induced astrocyte swelling in culture.

Authors:  Kakulavarapu V Rama Rao; Monica Brahmbhatt; Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2012-10-14       Impact factor: 3.584

10.  A dialogue between the hypoxia-inducible factor and the tumor microenvironment.

Authors:  Frédéric Dayan; Nathalie M Mazure; M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.